United Kingdom Biobank (UK Biobank) JACC Focus Seminar 6/8

An increasing number of people are now living with cardiovascular disease (CVD), with concomitant CVD-related hospitalizations, operations, and prescriptions. To ultimately deliver optimal cardiovascular care, access to population-based biobanks with data on multiomics, phenotypes, and lifestyle risk factors are crucial. UK Biobank is a cohort study that incorporated data between 2006 and 2010 from over half a million individuals (40 to 69 years of age) at recruitment from across the United Kingdom. As one of the most accessible, largest, and in-depth cohort studies in the world, UK Biobank continues to enhance the resource with the addition of data from various omics platforms (eg, genomics, metabolomics, proteomics), multimodal imaging, self-reported risk factors and health outcomes, and linkage to electronic health records. The vision of UK Biobank is to allow as many researchers as possible to apply their expertise and imagination to undertake research to prevent, diagnose, and treat a wide range of chronic conditions, including CVD. (J Am Coll Cardiol 2021;78:56-65) (c) 2021 Published by Elsevier on behalf of the American College of Cardiology Foundation.

Automated summary

UK Biobank is a large cohort study that provides rich data resources for researchers to prevent, diagnose, and treat a wide range of chronic conditions, including cardiovascular diseases, with a vision to allow as many researchers as possible to apply their expertise in utilizing the data.